Systematic review of parkinsonian syndromes in short- and long-term survivors of paraquat poisoning

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 11, 2011, Pages 1332-1336

  Brent, Jeffrey ^a,b,c   Schaeffer, Tammi H ^d  

^a Division of Clinical Pharmacology and Toxicology   (United States)

^b Children's Hospital Colorado   (United States)

^c Global Health and Health Disparities   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAQUAT;

ARTICLE; HUMAN; PARAQUAT POISONING; PARKINSONISM; SURVIVOR; TOXICITY TESTING;

PARKINSONIA;

EID: 81155135180     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e318233775d     Document Type: Article

References (32)

1. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinsons disease: a case control study in Taiwan. Neurology. 1997;48:1583-8.
2. Firestone JA, Smith-Weller T, Franklin G, Swanson P, LongstrethWT, Checkoway H. Pesticides and risk of Parkinsons disease. A population-based casecontrol study. Arch Neurol. 2005;62:91-95. (Pubitemid 40105040)
3. Kamel F, Tanner CM, Hoppin JA, et al. Pilot study of Parkinsons disease (PD) in the agricultural health study (AHS). Neurotoxicology. 2001;22:883-884.
4. Hertzman C, Wiens M, Bowering D, Snow B, Calne D. Parkinsons disease: a case-control study of occupational and environmental risk factors. Am J Ind Med. 1990;17:349-55. (Pubitemid 20155397)
5. Hertzman C, Wiens M, Snow B, Kelly S, Calne D. A case-control study of Parkinsons disease in a horticultural region of British Columbia. Mov Disord. 1994;9:69-75. (Pubitemid 24022617)
6. Kuopio AM, Martilla RJ, Helenius H, Rinne UK. Environmental risk factors in Parkinsons disease. Mov Disord. 1999;14:928-939.
7. Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinsons disease. J Occup Environ Med. 2005;47:1059-1087. (Pubitemid 41504815)
8. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinsons disease-is there a link? Enviro Health Persp. 2006;114:156-164. (Pubitemid 43193633)
9. Tanner CM, Aston DA. Epidemiology of Parkinsons disease and akinetic syndromes. Curr Opin in Neurol. 2000;13:427-430.
10. Lai BCL, Marion SA, Teschke K, Tsui JKC. Occupational and environmental risk factors for Parkinsons disease. Parkinsonism Relat Disord. 2002;8: 297-309. (Pubitemid 34520454)
11. Choi BC, Noseworthy AL. Classification, direction, and prevention of bias in epidemiologic research. J Occup Med. 1992;34: 265-271.
12. Davis GC, Williams AC, Markey SP, et al. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psych Res. 1979;1:249-254. (Pubitemid 10123385)
13. Langston JW, Ballard PA. Parkinsons disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med. 1983;309:310. (Pubitemid 13074924)
14. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979-980. (Pubitemid 13189531)
15. Orth M, Tabrizi SJ. Models of Parkinsons disease. Mov Disord. 2003;18: 729-737.
16. Lang AE, Lozano AM. Parkinsons disease-first of two parts. N Engl J Med. 1998;339:1044-1053.
17. Marsden CD. Parkinsons disease. J Neurol Neurosurg Psych. 1994;57: 672-681.
18. Langston JW. The etiology of Parkinsons disease with emphasis on the MPTP story. Neurology. 1996;47:S153-S160. (Pubitemid 26422581)
19. Alves G, Forsaa EB, Pedersen KF, Gjerstad MD, Larsen JP. Epidemiology of Parkinsons disease. J Neurol. 2008;255:18-32.
20. Talbot A. Paraquat and diquat. In: Brent J, Wallace K, Burkhart K, Phillips S, DonovanW, eds. Critical Care Toxicology Diagnosis and Management of the Critically Poisoned Patient. Philadelphia, PA: ElsevierMosby; 2005:947-961.
21. Rose MS, Smith LL, Wyatt I. Evidence for energy-dependent accumulation of paraquat into rat lung. Nature. 1974;252:314-315.
22. Smith LL. Young scientists award lecture 1981. The identification of an accumulation system for diamines and polyamines into the lung and its relevance to paraquat toxicity. Arch Toxico. 1982;l5:1-14. (Pubitemid 12067205)
23. Zilker TH, Fogt F, von Clarmann M. Kein Parkinsonsyndrom nach akuter Paraquatintoxikation. Klin Wochenschr. 1988; 66:1138-1141.
24. Naylor JL, Widdowson PS, Simpson MG, Farnworth M, Ellis MK, Lock EA. Further evidence that the blood-brain-barrier impedes paraquat entry into the brain. Hum Exp Toxicol. 1995;14:587-594.
25. Aleysin H, Rousseaux MW, Marcogliese PC, et al. DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci USA. 2010;107:3186-3191.
26. McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, DiMonte DA. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem. 2005;93:1030-1037. (Pubitemid 40695762)
27. Thomas B, Mohanakumar TB. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse nigrostriatum. J Pineal Res. 2004;36:25-32. (Pubitemid 38130286)
28. Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O. Carrier mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res. 2001;906:135-142. (Pubitemid 32595547)
29. Richardson JR, Quan Y, Sherer TB, Greenamyre JT, MillerGW. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci. 2005:193-204.
30. Bonneh-Barkay D, Reaney SH, LangstonWJ, DiMonte DA. Redox cycling of the herbicide paraquat inmicroglial cultures. Mol Brain Res. 2005;134:52-56. (Pubitemid 40403639)
31. McCormack AL, Atienza JG, Langston JW, Di Monte DA. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell population to paraquat-induced degeneration. Neuroscience. 2006;141: 929-937. (Pubitemid 44066639)
32. Bhidayasiri R, Boonyawairoj R. Spectrum of tardive syndromes: clinical recognition and management. Postgrad Med J. 2011;87:132-141.